K. Warrington

发表

Glucocorticoid usage in giant cell arteritis over six decades (1950 to 2009).

E. Matteson, K. Warrington, T. Kermani, 2015, Clinical and experimental rheumatology.

Incidence and predictors of thoracic aortic damage in biopsy-proven giant cell arteritis

C. Crowson, C. Labarca, K. Warrington, 2020, Scandinavian journal of rheumatology.

Immunoglobulin A vasculitis associated with inflammatory bowel disease: a retrospective cohort study

A. Makol, M. Koster, K. Warrington, 2020, Scandinavian journal of rheumatology.

The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009

E. Matteson, C. Crowson, K. Warrington, 2015, Scandinavian journal of rheumatology.

Concomitant giant cell arteritis and secondary adrenal insufficiency

A. Norgan, K. Warrington, A. Vella, 2015, Scandinavian journal of rheumatology.

LB0006 SARILUMAB IN PATIENTS WITH RELAPSING POLYMYALGIA RHEUMATICA: A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED TRIAL (SAPHYR)

F. Buttgereit, R. Spiera, A. Rubbert-Roth, 2022, Annals of the Rheumatic Diseases.

Outpatient healthcare utilization among incident cases of systemic sclerosis: results from a population-based US cohort (1988–2016)

A. Makol, E. Matteson, D. Asante, 2021, Scandinavian journal of rheumatology.

POS1377 LUNG INVOLVEMENT IN VEXAS SYNDROME

J. Ryu, K. Reichard, M. Baqir, 2022, Annals of the Rheumatic Diseases.

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients

X. Zhou, Y. Li, K. Knutson, 2023, medRxiv.